ZA874454B - Novel vaccenes - Google Patents

Novel vaccenes

Info

Publication number
ZA874454B
ZA874454B ZA874454A ZA874454A ZA874454B ZA 874454 B ZA874454 B ZA 874454B ZA 874454 A ZA874454 A ZA 874454A ZA 874454 A ZA874454 A ZA 874454A ZA 874454 B ZA874454 B ZA 874454B
Authority
ZA
South Africa
Prior art keywords
vaccenes
novel
novel vaccenes
Prior art date
Application number
ZA874454A
Other languages
English (en)
Inventor
Anthony Arthur Holder
Arthur Holder Anthony
Michael James Lockyer
James Lockyer Michael
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA874454B publication Critical patent/ZA874454B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ZA874454A 1986-06-20 1987-06-19 Novel vaccenes ZA874454B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868615068A GB8615068D0 (en) 1986-06-20 1986-06-20 Vaccines

Publications (1)

Publication Number Publication Date
ZA874454B true ZA874454B (en) 1989-01-25

Family

ID=10599794

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA874454A ZA874454B (en) 1986-06-20 1987-06-19 Novel vaccenes

Country Status (12)

Country Link
EP (1) EP0250261A1 (xx)
JP (1) JPS63503512A (xx)
AU (2) AU7542287A (xx)
DK (1) DK313687A (xx)
FI (1) FI872735A (xx)
GB (1) GB8615068D0 (xx)
NO (1) NO872586L (xx)
NZ (1) NZ220777A (xx)
PH (1) PH25860A (xx)
WO (1) WO1987007908A1 (xx)
ZA (1) ZA874454B (xx)
ZW (1) ZW11387A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002757A1 (en) * 1986-10-17 1988-04-21 Saramane Pty. Ltd.; Hybrid proteins or polypeptides
GB8819209D0 (en) * 1988-08-12 1988-09-14 Research Corp Ltd Polypeptide & dna encoding same
CA2037151A1 (en) * 1990-03-23 1991-09-24 F. Hoffmann-La Roche Ag Plasmodium sporozoite antigen
EP1105487A1 (en) 1998-08-21 2001-06-13 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by The Secretary, Department of Health and Human Services Recombinant multivalent malarial vaccine against plasmodium falciparum

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
AU584881B2 (en) * 1984-02-21 1989-06-08 British Technology Group Limited Improvements in or relating to the production of malaria vaccines
AU606042B2 (en) * 1985-12-24 1991-01-31 Saramane Pty Ltd Asexual blood stage antigens of plasmodium falciparum

Also Published As

Publication number Publication date
AU604711B2 (en) 1991-01-03
FI872735A0 (fi) 1987-06-18
WO1987007908A1 (en) 1987-12-30
GB8615068D0 (en) 1986-07-23
EP0250261A1 (en) 1987-12-23
AU7542287A (en) 1988-01-12
NO872586D0 (no) 1987-06-19
DK313687A (da) 1987-12-21
ZW11387A1 (en) 1989-01-25
DK313687D0 (da) 1987-06-19
NO872586L (no) 1987-12-21
PH25860A (en) 1991-12-02
AU7453687A (en) 1988-01-07
JPS63503512A (ja) 1988-12-22
FI872735A (fi) 1987-12-21
NZ220777A (en) 1990-12-21

Similar Documents

Publication Publication Date Title
PH23573A (en) Novel dialkylmaleimides
ZA875755B (en) Novel combination
AU99209S (en) Whirlpool-spa
ZA876543B (en) Novel 4-methylphthalimides
IL84818A0 (en) Novel dihydrothiadiazoles
ZA874454B (en) Novel vaccenes
GB2198131B (en) Novel prostacyclines
AU98619S (en) Gamesboard
GB2198130B (en) Novel prostacyclines
CA56175S (en) Presse-ail
CA57727S (en) Loudspeaker-cabinet
CA57624S (en) Chemisier
CA57305S (en) Dictating-machine
CA56801S (en) Eyeguard
CA57574S (en) Vitrine
CA55743S (en) Boardgame
CA57575S (en) Vitrine
CA57366S (en) Loudspeaker-cabinet
ZA875823B (en) Novel 9-deazaguanines
ZA873351B (en) Novel combination
BG41503A1 (en) Shampoon
BG41024A1 (en) Microfertilizer
BG41983A1 (en) Flag- former
BG42156A1 (en) Videocontroller
AU98600S (en) Airdam